Parkinson's Disease

In Tuesday’s pre-market trading, ANEW Medical, Inc. (NASDAQ:WENA) saw its shares surge nearly 80% following an announcement about the advancement of its patented Klotho gene therapy program for neurodegenerative disorders. What Happened: ANEW, a biopharmaceutical company that specializes in...

Renowned comedian Richard Lewis, known for his role in HBO’s ‘Curb Your Enthusiasm’, has passed away at 76. What Happened: Lewis, celebrated for his self-deprecating humor, died at his Los Angeles residence on Tuesday night. His publicist, Jeff Abraham, confirmed that a heart...

The study focused on the potential of rare cannabinoids in the treatment of neurodegenerative diseases like Alzheimer's. According to the researchers behind the study, this breakthrough research opens new avenues for addressing the unmet medical needs of patients with conditions like Alzheimer...

Specialty pharmaceutical company PharmaTher Holdings (OTCQB: PHRRF) has submitted a Fast Track Application to the Food and Drug Administration (FDA) for KETARX, a ketamine drug that may help treat levodopa-induced dyskinesia in Parkinson’s disease. Fast Track designation is for...

A new study has confirmed that pot-smoking bipeds are not the only creatures that get the munchies. Worms apparently experience cravings for their favorite snacks after consuming cannabis. Researchers at the University of Oregon said the tiny nematode worms they used for the...

PharmaTher Holdings Ltd. (OTCQB: PHRRF)’s recent meeting with the FDA on the feasibility of a Phase 3 program for proprietary ketamine KETARX to treat levodopa-induced dyskinesia in Parkinson’s disease (LID-PD) was successful, considering the federal agency supported the company’s...

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk's startup Neuralink brain chip could help treat morbid obesity; that's what Musk believes. Echoing Musk's statement, scientists say it's not an impossibility.  Responding to a Twitter post on the same line, Musk said that it is...

Alterity Therapeutics's (NASDAQ: ATHE) data in an animal model of Multiple System Atrophy (MSA) were published in the Journal of Parkinson's Disease.  The publication describes a study evaluating the efficacy of ATH434 in genetically altered mice that develop manifestations of...

This article by Chynna Pearson was originally published on Cannabis & Tech Today, and appears here with permission. Parkinson’s disease is a condition that affects populations all over the globe. In fact, it is estimated that over 10 million people live with the condition...

Zelira Therapeutics Limited (ASX: ZLD) (OTC: ZLDAF) declared Tuesday a partnership with the Parkinson's Foundation to find out how patients with Parkinson’s disease comprehend and use medical cannabis and hemp-derived therapies. Last year, the company was a part of the Medical Cannabis...

Prevail Therapeutics (NASDAQ: PRVL) shares are trading higher after the company received FDA fast track designation for PR001 for the treatment of Parkinson's disease patients with a GBA1 mutation. “We are pleased that the FDA has granted Fast Track Designation for PR001, which...

Thinly traded nanocap biotech Seelos Therapeutics Inc (NASDAQ: SEEL) is trading sharply higher on over three times its average volume. The company recently completed a reverse merger with Apricus Biosciences, and its shares have been trading under the ticker symbol SEEL. What Happened...

The Environmental Protection Agency is acting to mitigate health risks of paraquat dichloride — an herbicide commonly used in Syngenta AG (ADR) (NYSE: SYT) products — in response to fatalities from chemical ingestion and extended exposure. Paraquat Dichloride: More Than Just A Plant...